Global private equity and venture capital news and research

Posts Tagged ‘Sofinnova Ventures’

24 November 2015

Serious pregnancy condition drug developer nabs CHF60m VC-backed Series B

pregnant-244662_1920 Swiss biopharmaceutical company ObsEva, which develops drugs focusing on serious conditions compromising pregnancy, has raised a CHF60m ($59m) Series B round from a string of venture capital firms.

8 April 2015

Sofinnova Ventures helps gene testing business Natera to $55.5m funding round

DNAtrix Silicon Valley-based early-stage investment firm Sofinnova Ventures has led a $55.5m funding round for non-invasive genetic testing business Natera.

3 March 2015

Rock Springs, Sofinnova in cool $70m Series E for biopharma company Chiasma

syringe-m Venture capital investors Rock Springs Capital and Sofinnova Ventures have taken part in a sizable $70m funding round for US biopharmaceutical Chiasma.

9 January 2015

Sofinnova Ventures hires biotech veteran Welch as executive partner

Dan W_1420698769 Life sciences investor Sofinnova Ventures has hired former biotech CEO Daniel Welch as executive partner.

3 December 2014

Venture-backed gene therapy business Audentes nets $42.5m Series B

Audentes A string of venture capital firms have taken part in a $42.5m Series B financing round for gene therapy business Audentes Therapeutics.

1 December 2014

Growth hormone deficiency treatment company Ascendis picks up $60m VC-backed Series D

drug tablet pill medical pharma Sofinnova Ventures has joined with OrbiMed and Vivo Capital to lead a $60m Series D financing round for biotech business Ascendis Pharma.

10 November 2014

Healthcare platform MyTomorrows lands €4.5m from Balderton, Sofinnova

health healthcare drugs pills medication medical Balderton Capital and Sofinnova Partners have co-led a €4.5m financing round in Dutch healthcare platform MyTomorrows.

2 October 2014

Vivo, Fidelity and Sofinnova invest $21m in Aclaris

pills-1-569522-m Vivo Ventures, Fidelity Biosciences and Sofinnova Ventures have backed pharmaceutical company Aclaris Therapeutics in a $21m Series B financing round.

26 August 2014

Sofinnova, Rock Springs in $55m Series C for Parkinson’s relief pharma company

luxurary-74895-m Sofinnova Ventures, Rock Springs Capital and Adage Capital Management are among new investors in a sizable $55m funding round for biopharmaceutical company Civitas Therapeutics.

19 August 2014

Sofinnova-backed HealthQuest Capital raises $110m for debut fund

healthcare Sofinnova Ventures-backed venture capital firm HealthQuest Capital has held a final close of $110m for its debut fund.

Page 1 of 3123

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015